DSP-216

N/A

Report date: 2025/06/27 16:57:38

Base Information

Drug NameDSP-216
Drug Alias NameDSP-216
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAnti-HLA class I histocompatibility antigen, alpha chain GAnti-Cluster of differentiation 47
TargetsHLA class I histocompatibility antigen, alpha chain GCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKahr Medical
China Registration ClassN/A

Develop Information

Active CompaniesKahr Medical
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A